Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1985 3
1986 3
1987 2
1988 2
1991 2
1993 2
1994 5
1995 4
1996 4
1997 5
1998 10
1999 11
2000 6
2001 3
2002 7
2003 7
2004 9
2005 8
2006 4
2007 8
2008 9
2009 7
2010 9
2011 7
2012 8
2013 8
2014 8
2015 7
2016 17
2017 14
2018 8
2019 9
2020 14
2021 12
2022 12
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA. Soileau MJ, et al. Among authors: standaert dg. Lancet Neurol. 2022 Dec;21(12):1099-1109. doi: 10.1016/S1474-4422(22)00400-8. Lancet Neurol. 2022. PMID: 36402160 Clinical Trial.
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Obeso JA, et al. Among authors: standaert dg. Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Mov Disord. 2017. PMID: 28887905 Free PMC article. Review.
Scientific perspectives.
Standaert DG, Olanow CW, Obeso JA. Standaert DG, et al. Mov Disord. 2014 Sep;29(10):1230. doi: 10.1002/mds.26015. Mov Disord. 2014. PMID: 25209257 No abstract available.
Invisible Killers.
Volpicelli-Daley LA, Standaert DG. Volpicelli-Daley LA, et al. Among authors: standaert dg. Mov Disord. 2016 Jan;31(1):44. doi: 10.1002/mds.26465. Epub 2016 Jan 9. Mov Disord. 2016. PMID: 26748962 No abstract available.
Neuroprotective therapies.
Simon DK, Standaert DG. Simon DK, et al. Among authors: standaert dg. Med Clin North Am. 1999 Mar;83(2):509-23, viii. doi: 10.1016/s0025-7125(05)70117-6. Med Clin North Am. 1999. PMID: 10093591 Review.
John Q. Trojanowski, MD, PhD (1946-2022).
Hurtig HI, Standaert DG. Hurtig HI, et al. Among authors: standaert dg. Mov Disord. 2022 Jun;37(6):1123-1124. doi: 10.1002/mds.29053. Mov Disord. 2022. PMID: 35707825 No abstract available.
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Among authors: standaert dg. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
247 results